339 related articles for article (PubMed ID: 16105068)
41. Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model.
Song SH; Kwak IS; Yang BY; Lee DW; Lee SB; Lee MY
Nephrology (Carlton); 2009 Apr; 14(2):155-63. PubMed ID: 19207869
[TBL] [Abstract][Full Text] [Related]
42. miR-15a-5p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting VEGF in rats.
He Q; Wen L; Wang L; Zhang Y; Yu W; Zhang F; Zhang W; Xiao J; Wen X; Zhao Z
Ren Fail; 2020 Nov; 42(1):932-943. PubMed ID: 32909490
[TBL] [Abstract][Full Text] [Related]
43. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
44. Effect of the peritoneal dialysis prescription on pentosidine in children.
Bayazit AK; Vogt BA; Dell KM; Davis ID; Noyan A; Anarat A; Avner ED; Erhard P; Weiss MF
Pediatr Nephrol; 2003 Oct; 18(10):1049-54. PubMed ID: 12898376
[TBL] [Abstract][Full Text] [Related]
45. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
Zweers MM; Struijk DG; Smit W; Krediet RT
J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
[TBL] [Abstract][Full Text] [Related]
46. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
Miyata T; Sugiyama S; Saito A; Kurokawa K
Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
[TBL] [Abstract][Full Text] [Related]
47. Urea and uremic solutes: how does peritoneal dialysis work?
Bammens B
Semin Nephrol; 2011 Mar; 31(2):127-37. PubMed ID: 21439427
[TBL] [Abstract][Full Text] [Related]
48. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
[TBL] [Abstract][Full Text] [Related]
49. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
[TBL] [Abstract][Full Text] [Related]
50. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.
Alderson NL; Chachich ME; Youssef NN; Beattie RJ; Nachtigal M; Thorpe SR; Baynes JW
Kidney Int; 2003 Jun; 63(6):2123-33. PubMed ID: 12753299
[TBL] [Abstract][Full Text] [Related]
51. Effect of valsartan versus lisinopril on peritoneal sclerosis in rats.
Duman S; Sen S; Duman C; Oreopoulos DG
Int J Artif Organs; 2005 Feb; 28(2):156-63. PubMed ID: 15770604
[TBL] [Abstract][Full Text] [Related]
52. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
53. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
Padival S; Nagaraj RH
Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
[TBL] [Abstract][Full Text] [Related]
54. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.
Plum J; Hermann S; Fusshöller A; Schoenicke G; Donner A; Röhrborn A; Grabensee B
Kidney Int Suppl; 2001 Feb; 78():S42-7. PubMed ID: 11168981
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis.
Lapolla A; Flamini R; Lupo A; Aricò NC; Rugiu C; Reitano R; Tubaro M; Ragazzi E; Seraglia R; Traldi P
Ann N Y Acad Sci; 2005 Jun; 1043():217-24. PubMed ID: 16037242
[TBL] [Abstract][Full Text] [Related]
56. Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat.
Pedersen TF; Nielsen AH; Strandgaard S; Paulson OB
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):130-4. PubMed ID: 12228855
[TBL] [Abstract][Full Text] [Related]
57. Acute oxidative stress induces peritoneal hyperpermeability, mesothelial loss, and fibrosis.
Gotloib L; Wajsbrot V; Cuperman Y; Shostak A
J Lab Clin Med; 2004 Jan; 143(1):31-40. PubMed ID: 14749683
[TBL] [Abstract][Full Text] [Related]
58. Peritoneal effects of intravenous iron sucrose administration in rats.
Breborowicz A; Polubinska A; Breborowicz M; Simon M; Wanic-Kossowska M; Oreopoulos DG
Transl Res; 2007 Jun; 149(6):304-9. PubMed ID: 17543848
[TBL] [Abstract][Full Text] [Related]
59. Longitudinal evaluation of transport kinetics in children receiving peritoneal dialysis.
Warady BA; Fivush B; Andreoli SP; Kohaut E; Salusky I; Schlichting L; Pu K; Watkins S
Pediatr Nephrol; 1999 Sep; 13(7):571-6. PubMed ID: 10460503
[TBL] [Abstract][Full Text] [Related]
60. Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis.
Gillerot G; Devuyst O
Clin Nephrol; 2003 Jul; 60(1):1-6. PubMed ID: 12872851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
